DNAlytics

Chemin Du Cyclotron 6

1348 Ottignies-Louvain-La-Neuve

BE

DNAlytics

Foundation date

2012

Sector

#Biotechnology / R&D Services

Subsector

DNAlytics bases its activity on a Data Mining platform that it applies to develop personalized medicine solutions, from R&D to market access: diagnostic, prognostic and treatment response prediction, coupled with biomarker identification. DNAlytics has two main offers based on this technology platform: an expert consulting activity for pharmaceutical, biotech or IVD companies, and a product pipeline development. Its 1st product is RheumaKit, an early diagnostic solution for undifferentiated arthritis.

Upcoming events

Latest news

  • SeptiCyte® RAPID receives 510(k) clearance by US FDA

    Wednesday December 1st 2021

  • QbD and Inovigate launch Health to Market, a contract commercialization organization in life sciences

    Wednesday December 1st 2021

  • Dimitrios Mantzilas joins Precirix as Chief Technology Officer

    Wednesday December 1st 2021